Is there any association between COX2 and colon cancer?

May 22, 2009

Non-steroidal anti-inflammatory drugs (NSAIDs), which are known to reduce the risk of colon cancer, act directly on cyclooxygenase-2 (COX2) and reduce its activity. Population studies have found an association of inherited variations in the COX2 gene with colon cancer risk, but others were unable to replicate this finding. Similarly, variations in the uridine diphosphate glucuronosyltransferase 1A6 (UGT1A6) gene, which is also known to be key in the metabolism of NSAIDs, have been shown to modify the effect of NSAIDs on developing colon polyps, a precursor of colon cancer, but these modifications of NSAID effects have not been observed in risk of colon cancer.

A research article to be published on May 14, 2009 in the World Journal of Gastroenterology addresses this question. The research team led by Dr. Li from Case Western Reserve University examined the association of variants of the COX2 and UGT1A6 genes, and their interaction with NSAID consumption, on risk of colon cancer in attempt to more fully understand the relationship between genetic variation and the protective effect of NSAIDs on colon cancer risk.

They found that no single nucleotide polymorphisms (SNPs) in either gene were individually statistically significantly associated with colon cancer, nor did they statistically significantly change the protective effect of NSAID consumption. Like others, the authors were unable to replicate the association of variants in the COX2 gene with colon cancer risk (P > 0.05), and they did not observe that these variants modify the protective effect of NSAIDs (P > 0.05). Their study does not support a role of COX2 and UGT1A6 genetic variations in the development of colon cancer.

More information: Thompson CL, Plummer SJ, Merkulova A, Cheng I, Tucker TC, Casey G, Li L. No association between cyclooxygenase-2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer risk. World J Gastroenterol 2009; 15(18): 2240-2244 http://www.wjgnet.com/1007-9327/15/2240.asp

Source: World Journal of Gastroenterology (news : web)

Rate this story - 4 /5 (1 vote)

rank
1
2
3
4
5

view popular

Other News

Study identifies new way to biopsy brain tumors in real time

Medicine & Health / Neuroscience

11 minutes ago | not rated yet | 0

A new miniature, hand-held microscope may allow more precise removal of brain tumors and an easier recognition of tumor locations during surgery.

Why can't chimps speak? Study links evolution of single gene to human capacity for language

Medicine & Health / Genetics

3 hours ago | 4 / 5 (1) | 0

(PhysOrg.com) -- If humans are genetically related to chimps, why did our brains develop the innate ability for language and speech while theirs did not?

Researchers 'notch' a victory toward new kind of cancer drug

Medicine & Health / Cancer

2 hours ago | not rated yet | 0

Scientists have devised an innovative way to disarm a key protein considered to be "undruggable," meaning that all previous efforts to develop a drug against it have failed. Their discovery, published in the November 12 issue ...

Researchers find a weak link in cancer cell armor

Medicine & Health / Cancer

7 hours ago | 5 / 5 (3) | 0

(PhysOrg.com) -- Professor Robert Weiss has found that when two particular genes are inhibited, cancer cells are destroyed at a greater rate. The study is published in the Nov. 9 issue of PNAS.

New brain findings on dyslexic children

Medicine & Health / Neuroscience

3 hours ago | not rated yet | 0

The vast majority of school-aged children can focus on the voice of a teacher amid the cacophony of the typical classroom thanks to a brain that automatically focuses on relevant, predictable and repeating auditory information, ...